154 related articles for article (PubMed ID: 35750470)
1. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.
Chen L; Lu H; Peng D; Cao LL; Ballout F; Srirmajayam K; Chen Z; Bhat A; Wang TC; Capobianco A; Que J; McDonald OG; Zaika A; Zhang S; El-Rifai W
Gut; 2023 Mar; 72(3):421-432. PubMed ID: 35750470
[TBL] [Abstract][Full Text] [Related]
2. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.
Ballout F; Lu H; Chen L; Sriramajayam K; Que J; Meng Z; Wang TC; Giordano S; Zaika A; McDonald O; Peng D; El-Rifai W
J Exp Clin Cancer Res; 2022 Sep; 41(1):264. PubMed ID: 36045416
[TBL] [Abstract][Full Text] [Related]
3. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract][Full Text] [Related]
4. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
[TBL] [Abstract][Full Text] [Related]
5. Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells.
Sriramajayam K; Peng D; Lu H; Zhou S; Bhat N; McDonald OG; Que J; Zaika A; El-Rifai W
Redox Biol; 2021 Jul; 43():101970. PubMed ID: 33887608
[TBL] [Abstract][Full Text] [Related]
6. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
[TBL] [Abstract][Full Text] [Related]
7. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
8. Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis.
Peng DF; Hu TL; Soutto M; Belkhiri A; El-Rifai W
Carcinogenesis; 2014 Jul; 35(7):1620-8. PubMed ID: 24692067
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile exposure to simulated reflux leads to changes in gene expression in a 3D model of oesophageal mucosa.
Green NH; Nicholls Z; Heath PR; Cooper-Knock J; Corfe BM; MacNeil S; Bury JP
Int J Exp Pathol; 2014 Jun; 95(3):216-28. PubMed ID: 24713057
[TBL] [Abstract][Full Text] [Related]
11. The antioxidant response in Barrett's tumorigenesis: A double-edged sword.
Peng D; Zaika A; Que J; El-Rifai W
Redox Biol; 2021 May; 41():101894. PubMed ID: 33621787
[TBL] [Abstract][Full Text] [Related]
12. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA
Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241
[TBL] [Abstract][Full Text] [Related]
14. Bile acids induce Delta-like 1 expression via Cdx2-dependent pathway in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Aimi M; Oshima N; Yuki T; Sato S; Ishihara S; Kinoshita Y
Lab Invest; 2016 Mar; 96(3):325-37. PubMed ID: 26568294
[TBL] [Abstract][Full Text] [Related]
15. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
[TBL] [Abstract][Full Text] [Related]
16. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.
Quante M; Bhagat G; Abrams JA; Marache F; Good P; Lee MD; Lee Y; Friedman R; Asfaha S; Dubeykovskaya Z; Mahmood U; Figueiredo JL; Kitajewski J; Shawber C; Lightdale CJ; Rustgi AK; Wang TC
Cancer Cell; 2012 Jan; 21(1):36-51. PubMed ID: 22264787
[TBL] [Abstract][Full Text] [Related]
17. How does inflammation cause Barrett's metaplasia?
Colleypriest BJ; Ward SG; Tosh D
Curr Opin Pharmacol; 2009 Dec; 9(6):721-6. PubMed ID: 19828375
[TBL] [Abstract][Full Text] [Related]
18. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro.
Jenkins GJ; Harries K; Doak SH; Wilmes A; Griffiths AP; Baxter JN; Parry JM
Carcinogenesis; 2004 Mar; 25(3):317-23. PubMed ID: 14656946
[TBL] [Abstract][Full Text] [Related]
19. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
[TBL] [Abstract][Full Text] [Related]
20. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.
Zhou Z; Lu H; Zhu S; Gomaa A; Chen Z; Yan J; Washington K; El-Rifai W; Dang C; Peng D
J Exp Clin Cancer Res; 2019 Jan; 38(1):13. PubMed ID: 30626422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
